Lisata Therapeutics, Inc. (LSTA)
NASDAQ: LSTA · Real-Time Price · USD
2.225
+0.125 (5.94%)
May 12, 2025, 4:00 PM - Market closed
Lisata Therapeutics Revenue
Lisata Therapeutics had revenue of $1.00M in the twelve months ending March 31, 2025. In the year 2024, Lisata Therapeutics had annual revenue of $1.00M.
Revenue (ttm)
$1.00M
Revenue Growth
n/a
P/S Ratio
17.65
Revenue / Employee
$38,462
Employees
26
Market Cap
18.71M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
LSTA News
- 3 days ago - Lisata Therapeutics, Inc. (LSTA) Q1 2025 Earnings Conference Call Transcript - Seeking Alpha
- 4 days ago - Lisata Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 11 days ago - Lisata Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update on Thursday, May 8, 2025 - GlobeNewsWire
- 27 days ago - Lisata Therapeutics Announces Research License with Catalent - GlobeNewsWire
- 2 months ago - Lisata Therapeutics to Present at the Investival Showcase USA - GlobeNewsWire
- 2 months ago - Lisata Therapeutics and GATC Health Consummate First Step in Strategic Collaboration to use AI to Derisk and Accelerate Drug Development - GlobeNewsWire
- 2 months ago - Lisata Therapeutics, Inc. (LSTA) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Lisata Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update - GlobeNewsWire